OTC Markets OTCQB - Delayed Quote USD

Dogecoin Cash, Inc. (CBDS)

0.0264
-0.0006
(-2.22%)
At close: June 9 at 3:37:27 PM EDT
Loading Chart for CBDS
  • Previous Close 0.0270
  • Open 0.0290
  • Bid 0.0270 x 30449500
  • Ask 0.0289 x 10579900
  • Day's Range 0.0264 - 0.0290
  • 52 Week Range 0.0028 - 0.1662
  • Volume 361,183
  • Avg. Volume 629,457
  • Market Cap (intraday) 3.799M
  • Beta (5Y Monthly) 2.86
  • PE Ratio (TTM)
  • EPS (TTM) 0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Dogecoin Cash, Inc., through its subsidiaries, provides telemedicine online referral services for customers desiring medical marijuana cards in the United States. The company offers PrestoDoctor, an online telemedicine platform, which provides access to physicians for getting a medical marijuana recommendation using video conferencing technology. It also develops Lozenges for relief; Recover, a deep penetrating healing balm used to relieve pain for sore muscles, joints, arthritic, and back pain; Trauma Cream, a cream for blended infusion of cannabinoids and THC, as well as intends to offer hi branded men's and women's fashion from suppliers through its www.cbds.com website. In addition, the company holds intellectual property license for manufacture of medical marijuana edibles. It serves cannabidiol and cannabis industries. The company was formerly known as Cannabis Sativa, Inc. and changed its name to Dogecoin Cash, Inc. in November 2024. Dogecoin Cash, Inc. is based in Mesquite, Nevada.

www.cbds.com

4

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CBDS

View More

Performance Overview: CBDS

Trailing total returns as of 6/9/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

CBDS
69.66%
S&P 500 (^GSPC)
2.11%

1-Year Return

CBDS
13.30%
S&P 500 (^GSPC)
12.32%

3-Year Return

CBDS
81.14%
S&P 500 (^GSPC)
49.48%

5-Year Return

CBDS
95.88%
S&P 500 (^GSPC)
87.26%

Compare To: CBDS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CBDS

View More

Valuation Measures

Annual
As of 6/6/2025
  • Market Cap

    3.83M

  • Enterprise Value

    4.03M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.12

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    5.28

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -214.45%

  • Return on Assets (ttm)

    -21.20%

  • Return on Equity (ttm)

    -1,115.28%

  • Revenue (ttm)

    762.05k

  • Net Income Avi to Common (ttm)

    -1.63M

  • Diluted EPS (ttm)

    0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    360.51k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -106.08k

Research Analysis: CBDS

View More

Company Insights: CBDS

Research Reports: CBDS

View More

People Also Watch